Drug shortage: Sufentanil Citrate Injection (SUFENTANIL CITRATE)
FDA lists 4 presentations as Current. Availability: Unavailable (3), Available (1). Reason: Other. Companies: Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company.
- Published by source
- 2022-05-03
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Hikma Pharmaceuticals USA, Inc.
- Products
- Sufentanil Citrate Injection SUFENTANIL CITRATE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Not currently manufactured
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2022-05-03
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #999 | new | 2026-10-22 | e2742f7cf2d7…7f155e | b1443140ba49…291bf6 |
Chain head: #1076 8ad5adc30b9b…88ce20